HTB homepage • Conference reports • Articles by subject • Subscribe June 2008 Contents Editorial Volume 9 Number 5/6 May/June 2008 Conference reports 14th Annual BHIVA Conference, 23-25 April 2008, Belfast Overview of MRC studies in 2008 Initial results of BHIVA audit of HIV-related inpatient and day care in the UK Monitoring patients on antiretroviral therapy in resource-limited settings with viral load, CD4 count, or clinical observation alone Lower bilirubin increases in HCV-positive patients using atazanavir Cases of ventricular tachycardia and atazanavir/r and methadone Choice of ARVs for people after organ transplantation Use of fibroscan as non-invasive alternative to liver biopsy in HCV/HIV coinfection New-fill used to treat lipoatropy in feet Effect of 100mg ritonavir once- and twice-daily on lipids and cardiovascular markers in HIV-negative volunteers 15th Conference on Retroviruses and Opportunistic Infections, Boston, 2-6 February 2008 Immediate HAART reduces death and AIDS progression over 48 weeks in patients with acute OIs Utility of routine viral load, CD4 count and clinical monitoring among HIV-positive adults in rural Uganda Implementation of more complex regimens for prevention of mother-to-child transmission of HIV in Rwanda The estimated cost of switching from d4T to TDF in South Africa Gender differences in viral load by CD4 count in men and women Immune reconstitution inflammatory syndrome in young children initiating ART Complications with BCG vaccination in HIV-positive and negative infants: CHER Study The association between clinical characteristics and HIV-infection in very young infants Safety and efficacy of boosted darunavir in treatment-experienced children and adolescents at 24 weeks Responses to atazanavir-containing HAART in treatment-naive children in South Africa Initial growth, CD4, and viral load responses to HAART in Ugandan compared to UK/Irish HIV-positive children Paediatric pharmacokinetic studies A pilot study of three treatment strategies for HIV-positive infants Antiretrovirals Tibotec issue Dear Doctor letter and FDA require darunavir label change relating to hepatotoxicity Atazanavir 300mg capsule available Raltegravir approved in Scotland Abacavir, ddI and risk of heart attack: additional published data and statements from the EMEA and FDA Treatment access Key patient safety concern removed in new FDA guidance for non-US trials FDA approval of generic ARVs Paediatric care US paediatric guidelines updated (2008) New paediatric dosing recommendations for atazanavir Basic science and immunology Understanding control of HIV replication in the absence of therapy A surreal, deeply troubling week for AIDS vaccine research BHIVA news Draft BHIVA treatment guidelines online for comment Other news IAS calls for immediate release of Chinese activist Thailands war on drugs will undermine national AIDS fight and human rights: police given licence to kill drug users Activists criticise AIDS conference on opening day: Russian ban on substitution drug treatment is an Iron Curtain to ARV treatment Opportunities for healthcare workers to volunteer overseas On the web Conference reports and abstracts: 9th International Workshop on Clinical Pharmacology of HIV Therapy and 6th European HIV Drug Resistance Workshop New UK support group for gay men with HIV/HCV coinfection HCV pipeline report IHRD Harm Reduction Report TB – Online medical resources Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk PDFs Volume 9 Number 5/6 May/June 2008 PDF HTB homepage • Conference reports • Articles by subject • Subscribe